^
CANCER:

Fallopian Tube Cancer

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
No biomarker
Fallopian Tube Cancer
niraparib
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
bevacizumab
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
bevacizumab-awwb
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
Aybintio (bevacizumab biosimilar)
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
Sensitive
:
A1
BRCA1 mutation
Fallopian Tube Cancer
rucaparib
Sensitive
:
A1
BRCA2 mutation
Fallopian Tube Cancer
rucaparib
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
rucaparib
Sensitive
:
A1
BRCA2 mutation
Fallopian Tube Cancer
bevacizumab + olaparib
Sensitive
:
A1
BRCA1 mutation
Fallopian Tube Cancer
bevacizumab + olaparib
Sensitive
:
A1
HRD
Fallopian Tube Cancer
bevacizumab + olaparib
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
olaparib
Sensitive
:
A1
BRCA1 mutation
Fallopian Tube Cancer
niraparib
Sensitive
:
A1
BRCA2 mutation
Fallopian Tube Cancer
niraparib
Sensitive
:
A1
HRD
Fallopian Tube Cancer
niraparib
Sensitive
:
A1
BRCA2 mutation
Fallopian Tube Cancer
olaparib
Sensitive
:
A1
BRCA1 mutation
Fallopian Tube Cancer
olaparib
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
carboplatin + micellar paclitaxel
Sensitive
:
A1
BRCA1 mutation
Fallopian Tube Cancer
pamiparib
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
bevacizumab-maly
Sensitive
:
A1
BRCA2 mutation
Fallopian Tube Cancer
pamiparib
Sensitive
:
A1
No biomarker
Fallopian Tube Cancer
CAPOX
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
sorafenib
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
topotecan
Sensitive
:
A2
No biomarker
Fallopian Tube Cancer
pegylated liposomal doxorubicin
Sensitive
:
A2
MSI-H/dMMR
Fallopian Tube Cancer
pembrolizumab
Sensitive
:
A2
NTRK3 fusion
Fallopian Tube Cancer
larotrectinib
Sensitive
:
A2
NTRK2 fusion
Fallopian Tube Cancer
larotrectinib
Sensitive
:
A2
NTRK1 fusion
Fallopian Tube Cancer
larotrectinib
Sensitive
:
A2
NTRK3 fusion
Fallopian Tube Cancer
entrectinib
Sensitive
:
A2
NTRK2 fusion
Fallopian Tube Cancer
entrectinib
Sensitive
:
A2
NTRK1 fusion
Fallopian Tube Cancer
entrectinib
Sensitive
:
A2